(MOUNT LAUREL, NJ, September 5, 2019) — Optimizing neuron survival in the stroke-injured brain. Identifying which subjects will benefit from clinical trials for Alzheimer’s disease prevention. Testing a CAAR T cell strategy that prevents the devastation of autoimmune disease — these are just a few examples of the cutting-edge research that leading neuroscientists will present at the American Neurological Association’s 144th Annual Meeting, October 13–15, 2019 at the Marriott St Louis Grand.
Nearly a thousand of the nation’s top academic neurologists as well as students, trainees, and international professionals will convene for three days of research at the vanguard of neurology and neuroscience. A pre-meeting symposium the evening of October 12 will focus on Brain-Computer Interfaces in Neurological Disease.
A complete list of abstracts, under embargo until the start of the meeting October 13, will be made available to journalists on Friday, October 4.
For the second year, the meeting will feature a “Highlights of the Meeting” media roundtable on Tuesday, October 15, 2019 from 11:00 am to noon (CT), at which presenters of the six plenary sessions will present highlights, discuss the relevance of the work, and answer questions.